By analyzing the TCGA database, Ding et al. (Ding et al., 2022c) demonstrated that IGF2BP2-AS1 expression was elevated in BC tissues and was significantly associated with immune-related factors, indicating that IGF2BP2-AS1 is a potential therapeutic target for immune-related conditions. The gene discussed is IGF2BP2; the disease is breast cancer.